MARILYNE FAUSTIN: Open Payments
NPI 1225755762 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,739 in 65 payments from 12 companies in 2025. Trend: 2023 $665 · 2024 $2,346 · 2025 $2,739
Food & beverage: $2,739
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $482 |
| Janssen Pharmaceuticals, Inc | 8 | $421 |
| Alkermes, Inc. | 15 | $411 |
| E.R. Squibb & Sons, L.L.C. | 11 | $363 |
| Teva Pharmaceuticals USA, Inc. | 8 | $270 |
| Axsome Therapeutics, Inc. | 2 | $186 |
| ABBVIE INC. | 3 | $156 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Braeburn Inc. | 1 | $108 |
Products named: COBENFY, REXULTI, UZEDY, VIVITROL, INVEGA SUSTENNA, SPRAVATO, Auvelity, ARISTADA.
Industry payments across FL — which companies pay providers there.
